DSTN Hypomethylation Promotes Radiotherapy Resistance of Rectal Cancer by Activating the Wnt/-Catenin Signaling Pathway

Purpose: Although surgical resection combined with neoadjuvant radiation therapy can reduce the local recurrence rate of rectal cancer, not all patients benefit from neoadjuvant radiation therapy. Therefore, screening for patients with rectal cancer who are sensitive or resistant to radiation therapy has great clinical significance. Methods and Materials: Patients with rectal cancer were selected according to postoperative tumor regression grade, and tumor samples were taken for detection. Differential genes between radiation-resistant and radiation-sensitive tissues were screened and validated by Illumina Infinium Methylation EPIC BeadChip, proteomics, Agena Mass ARRAY methylation, reverse transcription quantitative real-time polymerase chain reaction, and immunohistochemistry. In vitro and in vivo functional experiments verified the role of DSTN. Protein coimmunoprecipitation, western blot, and immunofluorescence were used to investigate the mechanisms of DSTN-related radiation resistance. Results: DSTN was found to be highly expressed (P <.05) and hypomethylated (P <.01) in rectal cancer tissues resistant to neoadjuvant radiation therapy. Follow-up data confirmed that patients with high expression of DSTN in neoadjuvant radiation therapy resistant rectal cancer tissues had shorter disease-free survival (P <.05). DSTN expression increased after methyltransferase inhibitor inhibition of DNA methylation in colorectal cancer cells (P <.05). In vitro and in vivo experiments showed that knockdown of DSTN promoted the sensitivity of colorectal cancer cells to radiation therapy, and overexpression of DSTN promoted the resistance of colorectal cancer cells to radiation (P <.05). The Wnt/beta-catenin signaling pathway was activated in colorectal cancer cells overexpressing DSTN. beta-catenin was highly expressed in radiation therapy resistant tissues, and there was a linear correlation between the expression of DSTN and beta-catenin (P <.0001). Further studies showed that DSTN can bind to beta-catenin and increase its stability. Conclusions: The degree of DNA methylation and the expression level of DSTN can be used as biomarkers to predict the sensitivity of neoadjuvant radiation therapy for rectal cancer. DSTN and beta-catenin are also expected to become a reference for the selection of neoadjuvant radiation therapy. (c) 2023 Elsevier Inc. All rights reserved.